Vicki Moore, PhD

Contributing Writer https://www.rheumatologyadvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

General Medicine

Study Finds Suboptimal Iron Deficiency Screening During Pregnancy

Vicki Moore, PhD

January 25, 2022

Researchers sought to determine whether there was a discrepancy in the incidence of iron deficiency and screening for it in pregnant patients.

General Medicine

Requirements for Meaningful Involvement of Social Workers in Palliative Care

Vicki Moore, PhD

January 11, 2022

Researchers performing a literature review identified and described several requirements for meaningful involvement of social workers in palliative care.

Close to 60% of all patients with VHL will develop RCC or renal cysts.

General Rheumatology

Bone-Targeted Therapies and Incidence of Osteonecrosis of the Jaw in Metastatic Renal Cell Carcinoma

Vicki Moore, PhD

September 15, 2021

A retrospective analysis evaluated the incidence of ONJ in patients who received VEGF-TKIs or immune-oncology therapy for mRCC and bone-targeted therapies for bone metastases.

Pediatric Rheumatology

Chronic Hemolysis and Bone Health in Non-Transfusion-Dependent Pediatric Patients

Vicki Moore, PhD

April 9, 2021

Researchers evaluated growth as well as bone and body composition of non-transfusion-dependent (NTD) pediatric patients with chronic hemolysis.

Systemic Lupus Erythematosus

Outcomes of SLE in Immune-Mediated Thrombotic Thrombocytopenic Purpura

Vicki Moore, PhD

October 14, 2020

Thrombotic thrombocytopenic purpura related to SLE may not cause worse outcomes compared with primary immune-mediated TTP.

Systemic Lupus Erythematosus

Risk for SLE in Patients With Idiopathic Thrombocytopenic Purpura

Vicki Moore, PhD

April 17, 2020

Patients with idiopathic thrombocytopenic purpura may have a higher risk of systemic lupus erythematosus and should be monitored for incidental lupus.